Literature DB >> 11323763

Technical considerations and laparoscopic bile duct exploration: transcystic and choledochotomy.

E Lezoche1, A M Paganini.   

Abstract

Single-stage laparoscopic treatment of gallstones and common bile duct (CBD) stones is now challenging the traditional two-stage endo/laparoscopic approach. Many surgeons are reluctant to adopt this procedure because they believe this operation to be difficult and time-consuming. The aim of this report is to describe the technical details of the procedure and to demonstrate its effectiveness in a large series of unselected, consecutive patients. CBD stones were demonstrated in 301 unselected patients out of 2,894 undergoing laparoscopic cholecystectomy (10.4%) and were treated laparoscopically in 297 (98.6%), by the transcystic route in 185 patients (62.2%) and after choledochotomy in 112 patients (37.8%). Mean operative time was 119.2 minutes. Major complications were bile leakage (5 patients) and hemoperitoneum (4 patients) (3%). Retained CBD stones were observed in 14 patients (4.7%) and mortality in 1 high-risk patient (0.3%). Recurrent ductal stones occurred in 5 cases (1.6%) with dilated bile ducts, all after laparoscopic choledochotomy. Single-stage laparoscopic treatment of gallstones and CBD stones treats 2 problems during the same operation, avoids the additive complications of a second procedure (endoscopic sphincterotomy), and reduces hospital stay and costs. Laparoscopic management of ductal stones during laparoscopic cholecystectomy is the new "gold standard" for the treatment of gallstones and CBD stones. Copyright 2000 by W.B. Saunders Company.

Entities:  

Mesh:

Year:  2000        PMID: 11323763

Source DB:  PubMed          Journal:  Semin Laparosc Surg        ISSN: 1071-5517


  9 in total

1.  Laparoscopic management of common bile duct stones.

Authors:  S Ebner; J Rechner; S Beller; K Erhart; F M Riegler; G Szinicz
Journal:  Surg Endosc       Date:  2004-02-02       Impact factor: 4.584

2.  Laparoscopic exploration of the common bile duct with a rigid scope in patients with problematic choledocholithiasis.

Authors:  Ahmet Tekin; Zekai Ogetman
Journal:  World J Surg       Date:  2010-08       Impact factor: 3.352

Review 3.  Simultaneous laparoendoscopic rendezvous for the treatment of cholecystocholedocholithiasis.

Authors:  Gaetano La Greca; Francesco Barbagallo; Maria Sofia; Saverio Latteri; Domenico Russello
Journal:  Surg Endosc       Date:  2009-09-03       Impact factor: 4.584

Review 4.  Surgical versus endoscopic treatment of bile duct stones.

Authors:  Bobby V M Dasari; Chuan Jin Tan; Kurinchi Selvan Gurusamy; David J Martin; Gareth Kirk; Lloyd McKie; Tom Diamond; Mark A Taylor
Journal:  Cochrane Database Syst Rev       Date:  2013-12-12

5.  Laparoscopic cholecystectomy and common bile duct exploration are safe for older patients.

Authors:  A M Paganini; F Feliciotti; M Guerrieri; A Tamburini; R Campagnacci; E Lezoche
Journal:  Surg Endosc       Date:  2002-05-14       Impact factor: 4.584

6.  Comparison of long-term results of laparoscopic and endoscopic exploration of common bile duct.

Authors:  S S Rai; V V Grubnik; O L Kovalchuk; O V Grubnik
Journal:  J Minim Access Surg       Date:  2006-03       Impact factor: 1.407

7.  Laparo-endoscopic "Rendezvous" to treat cholecysto-choledocolithiasis: Effective, safe and simplifies the endoscopist's work.

Authors:  Gaetano La Greca; Francesco Barbagallo; Michele Di Blasi; Andrea Chisari; Rosario Lombardo; Rosario Bonaccorso; Saverio Latteri; Andrea Di Stefano; Domenico Russello
Journal:  World J Gastroenterol       Date:  2008-05-14       Impact factor: 5.742

8.  Why is there recurrence after transcystic laparoscopic bile duct clearance? Risk factor analysis.

Authors:  A Bove; G Bongarzoni; G Palone; R M Di Renzo; E M Calisesi; L Corradetti; M Di Nicola; L Corbellini
Journal:  Surg Endosc       Date:  2009-03-05       Impact factor: 4.584

Review 9.  Single-stage procedure for the treatment of cholecysto-choledocolithiasis: a surgical procedures review.

Authors:  Aldo Bove; Raffaella Maria Di Renzo; Gino Palone; Domenica Testa; Valentina Malerba; Giuseppe Bongarzoni
Journal:  Ther Clin Risk Manag       Date:  2018-02-20       Impact factor: 2.423

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.